Ken Griffin Atossa Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 67,600 shares of ATOS stock, worth $69,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,600

Previous 42,600 58.69%

Holding current value

$69,628

Previous $50,000 104.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.52 $43,162 - $60,190	-39,599 Reduced 19.65%	161,899 $246,000
Q2 2024 Aug 14, 2024	BUY	$1.03 - $2.1 $77,706 - $158,430	75,443 Added 59.85%	201,498 $239,000
Q1 2024 May 15, 2024	BUY	$0.8 - $1.89 $93,532 - $220,969	116,915 Added 1279.16%	126,055 $226,000
Q4 2023 Feb 14, 2024	SELL	$0.63 - $0.98 $22,690 - $35,295	-36,016 Reduced 79.76%	9,140 $8,000
Q3 2023 Nov 14, 2023	BUY	$0.74 - $1.35 $33,415 - $60,960	45,156 New	45,156 $33,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $22,587 - $45,626	45,175 Added 174.28%	71,096 $37,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $178,640 - $248,353	-217,854 Reduced 89.37%	25,921 $21,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.28 $856,126 - $1.29 Million	-1,007,208 Reduced 80.51%	243,775 $266,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $889,192 - $1.39 Million	-801,074 Reduced 39.04%	1,250,983 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $1.65 Million - $3.37 Million	1,030,350 Added 100.85%	2,052,057 $3.28 Million
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $2.85 Million - $6.32 Million	987,637 Added 2898.85%	1,021,707 $3.33 Million
Q1 2021 May 17, 2021	SELL	$0.92 - $4.33 $8,902 - $41,901	-9,677 Reduced 22.12%	34,070 $72,000
Q4 2020 Feb 16, 2021	BUY	$0.85 - $2.43 $16,341 - $46,716	19,225 Added 78.4%	43,747 $42,000
Q3 2020 Nov 16, 2020	BUY	$1.98 - $4.35 $28,163 - $61,874	14,224 Added 138.12%	24,522 $59,000
Q2 2019 Aug 14, 2019	SELL	$2.03 - $3.58 $48,987 - $86,392	-24,132 Reduced 70.09%	10,298 $26,000
Q4 2018 Feb 14, 2019	BUY	$0.92 - $1.67 $31,675 - $57,498	34,430 New	34,430 $35,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

26.5M

Call Options Held

466K

Put Options Held

91.8K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account